Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Melanoma 3Nasopharyngeal Carcinoma 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Vascular Complications 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Solid Tumor 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Oligoprogressive 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Mouth Neoplasms 1Meningeal Carcinomatosis 1Lung Neoplasms 1Locally Advanced Rectal Cancer 1Immune-Related Adverse Events 1Glioma 1Esophageal Squamous Cell Carcinoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

Bevacizumab 36atezolizumab 25durvalumab 22Nivolumab 21lenvatinib 20tremelimumab 15Specimen Handling 15Magnetic Resonance Spectroscopy 12sintilimab 11pembrolizumab 11Ipilimumab 10tislelizumab 7X-Rays 7Radiosurgery 7Immunoglobulin G 7regorafenib 6Sorafenib 6Disulfides 6Cyclophosphamide 6Radiotherapy 5cabozantinib 4Radiation 4Oxaliplatin 4Immunotherapy 4Fluorouracil 4Ethiodized Oil 4Blood Specimen Collection 4Biopsy 4fludarabine 3Photons 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Immune Checkpoint Inhibitors × 90 days × Clear all
NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute

Phase 4 Recruiting
160 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07466225 2026-03-12

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Peking University

Not yet recruiting
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡